Optellum, an Oxford-based MedTech company that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised around £13 million in a Series A funding round.  The investment will enable the company to scale its base, operations and commercial launches in the UK and USA, accelerate its research and development, and expand … Continue reading AI lung cancer diagnosis innovator Optellum secures £13m